Display options
Cite
Khorvash F, Abbasi S, Meidani M, et al. The comparison between proton pump inhibitors and sucralfate in incidence of ventilator associated pneumonia in critically ill patients. Adv Biomed Res. 2014;3:52doi: 10.4103/2277-9175.125789.
Khorvash, F., Abbasi, S., Meidani, M., Dehdashti, F., & Ataei, B. (2014). The comparison between proton pump inhibitors and sucralfate in incidence of ventilator associated pneumonia in critically ill patients. Advanced biomedical research, 352. https://doi.org/10.4103/2277-9175.125789
Khorvash, Farzin, et al. "The comparison between proton pump inhibitors and sucralfate in incidence of ventilator associated pneumonia in critically ill patients." Advanced biomedical research vol. 3 (2014): 52. doi: https://doi.org/10.4103/2277-9175.125789
Khorvash F, Abbasi S, Meidani M, Dehdashti F, Ataei B. The comparison between proton pump inhibitors and sucralfate in incidence of ventilator associated pneumonia in critically ill patients. Adv Biomed Res. 2014 Jan 27;3:52. doi: 10.4103/2277-9175.125789. eCollection 2014. PMID: 24627860; PMCID: PMC3950838.
Copy Download .nbib Format: NLM
Share it on

Adv Biomed Res. 2014 Jan 27;3:52. doi: 10.4103/2277-9175.125789. eCollection 2014.

The comparison between proton pump inhibitors and sucralfate in incidence of ventilator associated pneumonia in critically ill patients.

Advanced biomedical research

Farzin Khorvash, Saeed Abbasi, Mohsen Meidani, Fatemeh Dehdashti, Behrooz Ataei

Affiliations

  1. Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  2. Department of Anesthesiology, Isfahan University of Medical Sciences, Isfahan, Iran.
  3. Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

PMID: 24627860 PMCID: PMC3950838 DOI: 10.4103/2277-9175.125789

Abstract

BACKGROUND: Ventilator associated pneumonia (VAP) are one of the most common nosocomial infections in intensive care unit (ICU). The ICU patients are at risk of stress ulcer and gastrointestinal bleeding for different reasons. In order to prevent this complication, anti acids are used for patients. This study compared pantoprazole with sucralfate in incidence of ventilator associated pneumonia.

MATERIALS AND METHODS: This randomized clinical trial was carried out on ICU patients with mechanical ventilation in Alzahra university hospital in Isfahan from 2010 to 2011. One hundred forty eight ventilated patients were randomly allocated in two groups. The first group was treated with sucralfate and the second group was treated with pantoprazole for stress ulcer prophylaxis and followed up during hospitalization in ICU for nosocomial pneumonia. Data analyzed by SPSS software.

RESULTS: One hundred thirty seven patients were selected for study. During the study period, 34 cases (24.8%) acquired pneumonia, of which 10 were in the sucralfate group and 24 were in the pantoprazole group (14.1% vs. 36.4%). According to Chi-square test, rate of pneumonia was significantly lower in patients receiving sucralfate than the pantoprazole group (P < 0.001).

CONCLUSION: On the basis of the results, there is a significant relationship between the kind of drug used for stress ulcer and ventilator associated pneumonia. According to this article, rate of pneumonia was significantly lower in patients receiving sucralfate than the pantoprazole group.

Keywords: Pantoprazole; sucralfate; ventilator associated pneumonia

References

  1. Arch Surg. 1993 Feb;128(2):185-91; discussion 191-2 - PubMed
  2. Arch Surg. 1993 Dec;128(12):1353-7 - PubMed
  3. Clin Microbiol Rev. 2006 Oct;19(4):637-57 - PubMed
  4. Curr Opin Crit Care. 2009 Apr;15(2):139-43 - PubMed
  5. Intensive Care Med. 1997 Feb;23(2):187-95 - PubMed
  6. Chest. 2009 Aug;136(2):440-447 - PubMed

Publication Types